Should proximal LAD be treated differently? Insights from a large DES stent registry.
BACKGROUND
The current revascularization treatment recommendation is different according to lesion location and a higher recommendation is given to surgery for proximal LAD (pLAD) lesions over PCI. This is based on previous studies and expert opinion. We aimed to investigate whether indeed there is a difference in outcome with respect to LAD lesion location while using a drug eluting stent (DES).


METHODS
The NOBORI-2 trial, enrolled 3067 consecutive patients in 125 centers who were treated with DES for single and multivessel disease. We compared 834 [27.2%] patients who underwent PCI of the pLAD as part of their revascularization, to 2203 [71.8%] patients in which stenting to other lesion(s) but not the pLAD was performed.


RESULTS
The pLAD group had lower incidence of hypertension, peripheral vascular disease, prior PCI and CABG, but had more lesions treated [1.55 ± 0.8 vs. 1.35 ± 0.6], more stents implanted [1.98 ± 1.2 vs. 1.66 ± 1.0] and longer overall stent length [31.8 ± 20.2 vs. 28.2 ± 17.8 mm]. There was no difference in the occurrence of the primary endpoint [cardiac death, myocardial infarction and target lesion revascularization] at 1 or 2 years of follow up between the pLAD and non pLAD [6.0% vs. 4.6%, p=0.14 and 7.7% vs. 6.6%; p=0.22, respectively]. The relief from anginal symptoms was similar. Multivariate analysis showed that pLAD location was not a variable that predicted MACE or TLF. Stent thrombosis rate was similar.


CONCLUSIONS
When considering PCI with DES, there is no difference in outcome between patients with and without proximal LAD lesions.
Department of Cardiology, Rambam Medical Center, Haifa, Israel.
Arthur
A
Kerner
Eitan
E
Abergel
Majdi
M
Halabi
Amit
A
Soni
Gian Battista
GB
Danzi
Sergey
S
Yalonestky
Erik
E
Spaepen
Dragica
D
Paunovic
Eugenia
E
Nikolsky
Rafael
R
Beyar
Ariel
A
Roguin
D000368:Aged; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D003328:Coronary Thrombosis / Q000628:therapy*; D054855:Drug-Eluting Stents; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000628:therapy*; D012042:Registries; D016896:Treatment Outcome
Coronary disease; Guidelines; Outcome; Stents